Recall
FDAHealthDecember 23, 2024

Astellas Pharma US Inc. — Astagraf XL (tacrolimus extended-release capsules) 0.5 mg, 30-count bottles, RX Only, Product of Japan, Distributed by: Astellas Pharma US Inc., Northbrook, IL 60062, NDC 046

⚠️ Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
December 23, 2024

Nationwide in the USA

What's affected?

Product
Astagraf XL (tacrolimus extended-release capsules) 0.5 mg, 30-count bottles, RX Only, Product of Japan, Distributed by: Astellas Pharma US Inc., Northbrook, IL 60062, NDC 0469-0647-73.
Lot code
0R3092A

Additional details

Lot# 0R3092A, EXP 03/31/2026

What should I do?

Recommended action

Class I recall. Voluntary: Firm initiated Quantity affected: 3,500 30-count bottles.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.